scholarly journals Brainstem Raphe Alterations in TCS: A Biomarker for Depression and Apathy in Parkinson's Disease Patients

2018 ◽  
Vol 9 ◽  
Author(s):  
Daniel Richter ◽  
Dirk Woitalla ◽  
Siegfried Muhlack ◽  
Ralf Gold ◽  
Lars Tönges ◽  
...  
2017 ◽  
Vol 268 ◽  
pp. 45-49 ◽  
Author(s):  
Toomas Toomsoo ◽  
René Randver ◽  
Inga Liepelt-Scarfone ◽  
Liis Kadastik-Eerme ◽  
Toomas Asser ◽  
...  

2015 ◽  
Vol 37 (1) ◽  
pp. 45-50 ◽  
Author(s):  
Ying Chun Zhang ◽  
Hua Hu ◽  
Wei Feng Luo ◽  
Yu Jing Sheng ◽  
Xiao Fang Chen ◽  
...  

2018 ◽  
Vol 10 (2) ◽  
pp. 133-137 ◽  
Author(s):  
Hye Weon Kim ◽  
Hye Rin Yoon ◽  
Jong Sam Baik ◽  
Ji Eun Han ◽  
Sang Won Han ◽  
...  

2021 ◽  
Vol 11 (6) ◽  
pp. 776
Author(s):  
Cristina del Toro Pérez ◽  
Laura Amaya Pascasio ◽  
Antonio Arjona Padillo ◽  
Jesús Olivares Romero ◽  
María Victoria Mejías Olmedo ◽  
...  

Non-motor symptoms (NMS) in Parkinson’s disease (PD), including neuropsychiatric or dysautonomic complaints, fatigue, or pain, are frequent and have a high impact on the patient’s quality of life. They are often poorly recognized and inadequately treated. In the recent years, the growing awareness of NMS has favored the development of techniques that complement the clinician’s diagnosis. This review provides an overview of the most important ultrasonographic findings related to the presence of various NMS. Literature research was conducted in PubMed, Scopus, and Web of Science from inception until January 2021, retrieving 23 prospective observational studies evaluating transcranial and cervical ultrasound in depression, dementia, dysautonomic symptoms, psychosis, and restless leg syndrome. Overall, the eligible articles showed good or fair quality according to the QUADAS-2 assessment. Brainstem raphe hypoechogenicity was related to the presence of depression in PD and also in depressed patients without PD, as well as to overactive bladder. Substantia nigra hyperechogenicity was frequent in patients with visual hallucinations, and larger intracranial ventricles correlated with dementia. Evaluation of the vagus nerve showed contradictory findings. The results of this systematic review demonstrated that transcranial ultrasound can be a useful complementary tool in the evaluation of NMS in PD.


Author(s):  
Nuriye Yıldırım Gökay ◽  
Bülent Gündüz ◽  
Fatih Söke ◽  
Recep Karamert

Purpose The effects of neurological diseases on the auditory system have been a notable issue for investigators because the auditory pathway is closely associated with neural systems. The purposes of this study are to evaluate the efferent auditory system function and hearing quality in Parkinson's disease (PD) and to compare the findings with age-matched individuals without PD to present a perspective on aging. Method The study included 35 individuals with PD (mean age of 48.50 ± 8.00 years) and 35 normal-hearing peers (mean age of 49 ± 10 years). The following tests were administered for all participants: the first section of the Speech, Spatial and Qualities of Hearing Scale; pure-tone audiometry, speech audiometry, tympanometry, and acoustic reflexes; and distortion product otoacoustic emissions (DPOAEs) and contralateral suppression of DPOAEs. SPSS Version 25 was used for statistical analyses, and values of p < .05 were considered statistically significant. Results There were no statistically significant differences in the pure-tone audiometry thresholds and DPOAE responses between the individuals with PD and their normal-hearing peers ( p = .732). However, statistically significant differences were found between the groups in suppression levels of DPOAEs and hearing quality ( p < .05). In addition, a statistically significant and positive correlation was found between the amount of suppression at some frequencies and the Speech, Spatial and Qualities of Hearing Scale scores. Conclusions This study indicates that medial olivocochlear efferent system function and the hearing quality of individuals with PD were affected adversely due to the results of PD pathophysiology on the hearing system. For optimal intervention and follow-up, tasks related to hearing quality in daily life can also be added to therapies for PD.


Sign in / Sign up

Export Citation Format

Share Document